← SynDRA
HALOMETASONE
SynDRA canonical compound SYN0025601 — structure-anchored drug synonym record
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | Glucocorticoid receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PGR
- ACHE
- KCNH2
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- HTR2B
- ADORA3
- HTR1A
- HRH3
- GAA
- F2
- ESR1
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP2CJ
- CP3A4
- CP3A7
- GCR
- GLI3
- KCMB1
- KCMB4
- KSYK
- NR1I2
- PRGR
- SYK
Drug classes
- Anti-Inflammatory Agents
- Dermatologic Agents
- Glucocorticoids
- Hormones
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
Cross-references
Synonyms
- halomethasone
- sicorten
- Halometasona
- Sicorten (TN)
- Halometasonum
- J69Z9UU41Z
- RefChem:145096
- DTXCID7028356
- D07AC12
- C-48,401-Ba
- Halometasone [INN]
- Halometasone (INN)
- SMR000466330
- Halometasonum [INN-Latin]
- Halometasona [INN-Spanish]
- UNII-J69Z9UU41Z
- C22H27ClF2O5
- EINECS 256-664-9
- HALOMETASONE [MI]
- SCHEMBL4872
- HALOMETASONE [MART.]
- MLS000759439
- MLS001424089
- HALOMETASONE [WHO-DD]
- orb1693789
- CHEBI:135724
- GGXMRPUKBWXVHE-MIHLVHIWSA-N
- HMS2051C16
- HMS2232N17
- MFCD00941424
- MSK011036
- AKOS025402048
- AC-3528
- CCG-100880
- HY-W341962
- MSK011036-100A
- NC00130
- MSK011036-1000A
Look up HALOMETASONE in the interactive SynDRA portal →